earnings
NASDAQ · AYTU
Aytu BioPharma, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$2.37
Up+$0.09 (+3.95%)
Updated Aug 24, 2026, 3:20 AM
SID Score
4.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 16.53M
- P/E ratio
- -1.68
- Dividend yield
- 0.00%
- 52-week range
- $1.65 – $3.07
- Volume
- 52.35K
- Avg. volume
- 176.83K
Price performance
AYTU price history
1M range · 20 trading sessions · Daily adjusted prices
AYTU closed at $2.37 after 20 trading sessions, up 15.05% for the selected period.
- Last close
- $2.37
- Period change
- +15.05%
- Period low
- $2.06
- Period high
- $2.40
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $2.25 | $2.40 | $2.2213 | $2.37 | 52.35K |
| Aug 20, 2026 | $2.36 | $2.365 | $2.27 | $2.28 | 33.94K |
| Aug 19, 2026 | $2.38 | $2.40 | $2.3598 | $2.36 | 60.43K |
| Aug 18, 2026 | $2.35 | $2.39 | $2.35 | $2.36 | 32.42K |
| Aug 17, 2026 | $2.36 | $2.38 | $2.35 | $2.36 | 16.08K |
| Aug 14, 2026 | $2.33 | $2.4056 | $2.33 | $2.38 | 55.62K |
| Aug 13, 2026 | $2.38 | $2.395 | $2.2501 | $2.30 | 43.53K |
| Aug 12, 2026 | $2.40 | $2.40 | $2.36 | $2.36 | 18.27K |
| Aug 11, 2026 | $2.405 | $2.42 | $2.37 | $2.4005 | 19.32K |
| Aug 10, 2026 | $2.33 | $2.46 | $2.33 | $2.38 | 30.32K |
| Aug 7, 2026 | $2.3104 | $2.36 | $2.29 | $2.36 | 38.14K |
| Aug 6, 2026 | $2.27 | $2.33 | $2.23 | $2.33 | 29.03K |
| Aug 5, 2026 | $2.18 | $2.33 | $2.18 | $2.30 | 49.8K |
| Aug 4, 2026 | $2.26 | $2.2999 | $2.20 | $2.21 | 22.16K |
| Aug 3, 2026 | $2.25 | $2.28 | $2.2301 | $2.25 | 23.38K |
| Jul 31, 2026 | $2.16 | $2.25 | $2.13 | $2.23 | 73.17K |
| Jul 30, 2026 | $2.16 | $2.18 | $2.12 | $2.15 | 20.71K |
| Jul 29, 2026 | $2.16 | $2.1785 | $2.07 | $2.08 | 42.7K |
| Jul 28, 2026 | $2.1285 | $2.15 | $2.09 | $2.13 | 21.32K |
| Jul 27, 2026 | $2.16 | $2.20 | $2.03 | $2.06 | 38.06K |
Latest AYTU news
The latest Smart Investors Daily articles mentioning AYTU.
Stock researchCompany · Earnings
Loading stock research…